BSE - Delayed Quote INR
Dr. Lal PathLabs Limited (LALPATHLAB.BO)
2,808.30
+49.75
+(1.80%)
At close: 3:29:24 PM GMT+5:30
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
24,614,000
24,614,000
22,266,000
20,166,430
20,874,000
Cost of Revenue
4,815,000
4,815,000
4,514,000
7,291,860
5,023,000
Gross Profit
19,799,000
19,799,000
17,752,000
12,874,570
15,851,000
Operating Expense
10,846,000
10,846,000
9,965,000
9,359,930
8,480,000
Operating Income
8,953,000
8,953,000
7,787,000
3,514,640
7,371,000
Net Non Operating Interest Income Expense
-223,000
-223,000
-294,000
-43,550
-302,000
Pretax Income
6,247,000
6,247,000
5,055,000
3,438,270
4,749,000
Tax Provision
1,325,000
1,325,000
1,432,000
1,027,500
1,246,000
Net Income Common Stockholders
4,871,000
4,871,000
3,577,000
2,388,480
3,448,000
Diluted NI Available to Com Stockholders
4,871,000
4,871,000
3,577,000
2,388,480
3,448,000
Basic EPS
58.48
58.48
43.05
28.82
41.70
Diluted EPS
58.40
58.40
42.98
28.74
41.57
Basic Average Shares
83,293.43
83,293.43
83,089.43
82,864.44
82,685.85
Diluted Average Shares
83,407.53
83,407.53
83,224.76
83,117.94
82,944.43
Rent Expense Supplemental
--
--
271,690
248,960
260,560
Total Expenses
15,661,000
15,661,000
14,479,000
16,651,790
13,503,000
Net Income from Continuing & Discontinued Operation
4,871,000
4,871,000
3,577,000
2,388,480
3,448,000
Normalized Income
4,871,000
4,871,000
3,577,000
2,411,702.35
3,448,000
Interest Income
--
--
554,300
331,780
472,610
Interest Expense
223,000
223,000
294,000
375,330
302,000
Net Interest Income
-223,000
-223,000
-294,000
-43,550
-302,000
EBIT
6,470,000
6,470,000
5,349,000
3,813,600
5,051,000
EBITDA
7,889,000
7,889,000
6,785,000
5,315,530
6,132,000
Reconciled Cost of Revenue
4,815,000
4,815,000
4,514,000
7,291,860
5,023,000
Reconciled Depreciation
1,419,000
1,419,000
1,436,000
1,501,930
1,081,000
Net Income from Continuing Operation Net Minority Interest
4,871,000
4,871,000
3,577,000
2,388,480
3,448,000
Total Unusual Items Excluding Goodwill
--
--
103,900
-33,120
37,530
Total Unusual Items
--
--
103,900
-33,120
37,530
Normalized EBITDA
7,889,000
7,889,000
6,785,000
5,348,650
6,132,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
-9,897.65
--
3/31/2022 - 12/23/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade